PharmaSUG2018paper·US·ePostersAnalyzing Adverse Events of Special Interest using Lab Tests and Toxicity Grades EP20See metadata
PharmaSUG2018paper·US·ePostersExperience of electronic data submission via Gateway to PMDA EP21See metadata
PharmaSUG2018paper·US·ePostersSummary Table for Displaying Results of a Logistic Regression Analysis EP23See metadata
PharmaSUG2018paper·US·ePostersA SAS Macro to Create Validation Summary of Dataset Report EP25See metadata
PharmaSUG SDE2018paper·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentElectronic Data Submission and Utilization in Japan 01 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018paper·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentNew CFDA Requirements in NDA and Its Implementation in Process (English only) 02 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018paper·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentBest Practice for e-Study Data Submission to PMDA 03 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018paper·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentData Mapping Using Machine Learning 04 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018paper·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentAutomated Generation of PowerPoint Presentations Using R in Clinical Studies 05 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018paper·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentUsing R-Shiny as a Data Reviewing and Validation Tool in Clinical Trials (English only) 06 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018paper·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentPast and Future of Our AI Making Use of Data Governance: How to Make Process/Product Innovations 07 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018paper·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentTechnology Overview About Artificial Intelligence for Clinical Data Science 08 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018paper·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentMapping Reported Term for the Adverse Event into MedDRA Using Deep Learning 09 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018paper·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentSimulation Study to Use “REAL World Data” Using RDB and Hadoop 10 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018paper·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentWe Choose Intelligent Chatbot or AI Chatbot? 11 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018poster·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentThe Implementation of RBM in Chugai PO01 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018poster·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentDealing with Time-Varying Confounding Using SAS PO02 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018poster·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentData Visualization by Python: Data from Pandas to Matplotlib PO03 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018poster·Japan·Analytic Evolution: Exploring the Next Phase of Drug DevelopmentCase Study on Central Monitoring in RBM PO04 Asia-Pacific · Tokyo, JapanSee metadata
PharmaSUG SDE2018presentation·NC·Sharing Solutions of e-Submissions: Making it Happen, Making it MatterAdvanced Visualization Using TIBCO Spotfire and SAS Using SDTM Data 01 North America · RTP, NCSee metadata